Friday, 23 February 2018

FDA approves KemPharm's opioid painkiller

(Reuters) - KemPharm Inc said on Friday the U.S. Food and Drug Administration approved its opioid painkiller Apadaz for the short-term management of acute pain.


Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)